Drug profile · INN
tipiracil hydrochloride
LONSURF
tipiracil hydrochloride (LONSURF) is a thymidine phosphorylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tipiracil hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
tipiracil hydrochloride (LONSURF) is a thymidine phosphorylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Thymidine phosphorylase inhibitor
Primary target: Thymidine phosphorylase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is tipiracil hydrochloride?
tipiracil hydrochloride (LONSURF) is a thymidine phosphorylase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tipiracil hydrochloride?
LONSURF is a marketed brand name for tipiracil hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tipiracil hydrochloride?
tipiracil hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.